These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 1458889)

  • 1. Risk factors for copper T IUD expulsion: an epidemiologic analysis.
    Zhang J; Feldblum PJ; Chi IC; Farr MG
    Contraception; 1992 Nov; 46(5):427-33. PubMed ID: 1458889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Twelve-month comparative multicenter study of the TCu 380A and ML 250 intrauterine devices in Bangkok, Thailand.
    Reinprayoon D; Gilmore C; Farr G; Amatya R
    Contraception; 1998 Oct; 58(4):201-6. PubMed ID: 9865999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
    Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
    Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary report on a postpartum CuT 200 study, Santiago, Chile.
    Lavin P; Waszak C; Bravo C
    Int J Gynaecol Obstet; 1983 Feb; 21(1):71-5. PubMed ID: 6133798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Five years private practice experience of nulliparous women using copper IUD's.
    Smith RP; Goresky DM; Etchell DM
    Contraception; 1980 Apr; 21(4):335-42. PubMed ID: 7389354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of age and parity with intrauterine device expulsion.
    Madden T; McNicholas C; Zhao Q; Secura GM; Eisenberg DL; Peipert JF
    Obstet Gynecol; 2014 Oct; 124(4):718-726. PubMed ID: 25198262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of the levonorgestrel-releasing IUD: its advantages and disadvantages when compared to the copper-releasing IUDs.
    Chi IC
    Contraception; 1991 Dec; 44(6):573-88. PubMed ID: 1773615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term contraception with the levonorgestrel 20 mcg/day (LNg 20) and the copper T 380Ag intrauterine devices: a five-year randomized study.
    Sivin I; el Mahgoub S; McCarthy T; Mishell DR; Shoupe D; Alvarez F; Brache V; Jimenez E; Diaz J; Faundes A
    Contraception; 1990 Oct; 42(4):361-78. PubMed ID: 2124179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Menstrual bleeding with copper-covered intrauterine contraceptive devices.
    Malmqvist R; Petersohn L; Bengtsson LP
    Contraception; 1974 Jun; 9(6):627-33. PubMed ID: 4448089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of the clinical performance of two copper-releasing IUDs, Nova-T & Copper-T-200 in Lagos, Nigeria.
    Oyediran MA; Akinla O
    Contraception; 1980 Aug; 22(2):115-22. PubMed ID: 7004771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A collaborative study of the progesterone intrauterine device (Progestasert). The World Health Organization Task Force on Methods for the Regulation of Implantation.
    Newton J; Szontagh F; Lebech P; Rowe P
    Contraception; 1979 Jun; 19(6):575-89. PubMed ID: 487808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demographic, Reproductive, and Medical Risk Factors for Intrauterine Device Expulsion.
    Anthony MS; Zhou X; Schoendorf J; Reed SD; Getahun D; Armstrong MA; Gatz J; Peipert JF; Raine-Bennett T; Fassett MJ; Saltus CW; Ritchey ME; Ichikawa L; Shi JM; Alabaster A; Wahdan Y; Wang J; Xie F; Merchant M; Hunter S; Chiu VY; Postlethwaite D; Rothman KJ; Im TM; Chillemi G; Takhar HS; Asiimwe A; Pisa F
    Obstet Gynecol; 2022 Dec; 140(6):1017-1030. PubMed ID: 36357958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The safety of intrauterine devices among young women: a systematic review.
    Jatlaoui TC; Riley HEM; Curtis KM
    Contraception; 2017 Jan; 95(1):17-39. PubMed ID: 27771475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immediate postabortion intrauterine contraception in nulliparous adolescents.
    Goldman JA; Dekel A; Reichman J
    Isr J Med Sci; 1979 Jun; 15(6):522-5. PubMed ID: 457386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-year rates for Nova T and Copper T in a comparative study.
    Allonen H; Luukkainen T; Nielsen NC; Nygren KG; Pyörälä T
    Contraception; 1980 Apr; 21(4):321-34. PubMed ID: 6993095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of copper intrauterine devices when inserted after an expulsion.
    Bahamondes L; Díaz J; Marchi NM; Petta CA; Cristofoletti ML; Gomez G
    Hum Reprod; 1995 Nov; 10(11):2917-8. PubMed ID: 8747044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Menstrual blood loss, haemoglobin and ferritin concentration of Beijing women wearing steel ring, VCu 200, and TCu 220c IUDs.
    Gao J; Zeng S; Sun BL; Wu SC; Dong J; Cong J; Zhu XH; Fan HM; Han LH; Xie Z
    Contraception; 1986 Dec; 34(6):559-71. PubMed ID: 3829674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of the effect of the Progestasert TM and Gravigard IUDs on dysmenorrhoea.
    Pizarro E; Gomez-Rogers C; Rowe PJ
    Contraception; 1979 Nov; 20(5):455-66. PubMed ID: 527341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Timing of the IUD insertion.
    Edelman DA; Zipper J; Rivera M; Medel M
    Contraception; 1979 May; 19(5):449-54. PubMed ID: 467054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.